To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.
118th Congress
Introduced Sep 13, 2023
Sponsors
Legislative Progress
Introduced
Introduced
Committee
Passed
Sep 13, 2023
Ms. Hassan (for herself and Mr. Braun) introduced the following …
Sep 13, 2023
Ms. Hassan (for herself and Mr. Braun) introduced the following …
Sep 13, 2023
Ms. Hassan (for herself and Mr. Braun) introduced the following …
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology